First human evidence that nasal vaccine could prevent type 1 diabetes

First human evidence that nasal vaccine could prevent type 1 diabetes


Walter and Eliza Hall Institute and Royal Melbourne Hospital researchers have provided the first evidence in humans that a nasal spray vaccine which is being trialled at The Royal Melbourne Hospital could prevent the development of type 1 diabetes.
Professor Len Harrison from the institute’s Immunology division and Professor Peter Colman and Dr Spiros Fourlanos from

Medical Insurance